A UCLA research team has identified the best design for a promising new type of immunotherapy that could be mass-produced to ...

Company’s lead program, GRI-0621, has demonstrated ability to inhibit the activity of type I invariant NKT (iNKT) cells early in the inflammatory cascade to prevent cytokine release, cellular ...

Natural killer T (NKT) cells are innate-like T cells that share properties of both NK cells and T lymphocytes. NKT cells are pre-loaded with cytokine message and respond quickly in immune responses, ...

Access the “What This Means” segment hereLA JOLLA, CA, Feb. 17, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the ...

In this development, I Peace successfully created proprietary technology that enables the selective and efficient expansion of NKT cells. Using this technology, the company established iPS cells and ...

A UCLA research team has identified the best design for a promising new type of immunotherapy that could be mass-produced to ...

Immunotherapy. 2011;3(10):1167-1184. Specifically, iNKT cells appear to inhibit early disease progression with their loss facilitating disease progression, while at later inflammatory stages, NKT ...

Company continues to advance an innovative pipeline of NKT cell regulators for the treatment of high-value inflammatory, fibrotic and autoimmune diseases LA JOLLA, CA, Sept. 30, 2024 (GLOBE NEWSWIRE) ...

Natural killer T (NKT) cells shape the immune response to dengue virus, determining whether the antibodies produced are protective or potentially harmful in future infections. Singapore, 20 September ...

Triple-negative breast cancer is one of the most aggressive cancers. The name tells the story: It lacks the three main targets that make other types of breast cancers more treatable with powerful ...

Phase I clinical trials, using αGalCer-loaded DCs to target iNKT cells, have shown promise in treating some patients with cancer. As humans have a low frequency of iNKT cells, therapies that combine ...